Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
771.4 JPY | +0.98% | +2.02% | +5.20% |
May. 27 | Toray Industries to Build Advanced Materials Production Plant in South Korea's Gumi City | MT |
May. 22 | Immunis Partners with Toray to Reverse Sarcopenia | CI |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.75 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.20% | 7.56B | B+ | ||
+1.24% | 101B | A- | ||
-11.38% | 59.19B | A- | ||
+80.95% | 50.62B | B | ||
+1.21% | 33.55B | B | ||
-2.35% | 30.23B | A- | ||
+0.99% | 18.17B | B- | ||
+16.72% | 17.33B | C+ | ||
+4.48% | 13.31B | B- | ||
+85.52% | 13.4B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 3402 Stock
- Ratings Toray Industries, Inc.